Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Telemedicine boosts lymphoma care in major french study

NCT ID NCT03336138

First seen Jan 04, 2026 · Last updated May 01, 2026 · Updated 15 times

Summary

This study looked at whether using telemedicine (remote doctor visits and monitoring) can improve how well patients with aggressive lymphoma receive their chemotherapy. Researchers compared a group using telemedicine support to a control group, measuring how much of the planned full-dose treatment patients actually got. The study involved 350 patients across 10 hospitals in France.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Bayonne Hospital

    Bayonne, 64000, France

  • Clinique Claude Bernard

    Albi, 81000, France

  • Clinique Marzet

    Pau, 64000, France

  • Clinique Saint Jean

    Toulouse, 31000, France

  • Hospital

    Auch, 32000, France

  • Hospital

    Montauban, 82000, France

  • Rodez Hospital

    Rodez, 12000, France

  • Tarbes Hospital

    Tarbes, 65000, France

  • University Hospital Bordeaux

    Bordeaux, 33000, France

  • University Hospital of Toulouse

    Toulouse, France, France

Conditions

Explore the condition pages connected to this study.